Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

N4BP3 Activators

N4BP3 activators encompass a variety of chemical compounds that utilize cellular signaling cascades to amplify the functional activity of this protein. Central to many of these mechanisms is the elevation of intracellular cyclic AMP (cAMP) levels, an essential secondary messenger that regulates a multitude of cellular processes. The increase in cAMP is typically achieved through the activation of adenylyl cyclase or inhibition of phosphodiesterases, enzymes responsible for cAMP synthesis and degradation, respectively. Once cAMP levels are elevated, protein kinase A (PKA), a cAMP-dependent kinase, becomes activated. PKA plays a pivotal role in the phosphorylation of a broad spectrum of substrates, including N4BP3, thereby enhancing its activity. Some activators directly stimulate adenylyl cyclase, whereas others, like certain β-adrenergic agonists, act on G protein-coupled receptors to modulate the enzyme's activity. Additionally, inhibitors of phosphodiesterase create a similar effect by preventing the breakdown of cAMP, thus sustaining the activation signal.

Another layer of regulation comes from modulators of intracellular calcium levels, which can indirectly influence N4BP3 activity. Calcium ionophores, for example, facilitate the influx of calcium ions into the cell, which can activate calcium-dependent kinases. These kinases have the potential to phosphorylate N4BP3, similar to how PKA functions in the cAMP pathway. The convergence of cAMP and calcium signaling pathways illustrates the intricate network of biochemical events that lead to the functional activation of N4BP3. The chemical compounds that target these pathways are diverse in structure and origin, but function to enhance the phosphorylation status and consequently the activity of N4BP3.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Activates protein kinase C (PKC) which can phosphorylate N4BP3, potentially increasing its activity.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Increases intracellular calcium concentration, potentially activating calcium-dependent kinases that could phosphorylate N4BP3, leading to an increase in its activity.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

A cell-permeable cAMP analog that activates PKA, potentially leading to the phosphorylation and activation of N4BP3.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

A β-adrenergic agonist that elevates cAMP levels, indirectly leading to the activation of PKA and potential phosphorylation of N4BP3.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A calcium ionophore that raises intracellular calcium levels, potentially leading to the activation of calcium-dependent kinases and subsequent phosphorylation of N4BP3.

8-Bromo-cAMP

76939-46-3sc-201564
sc-201564A
10 mg
50 mg
$126.00
$328.00
30
(1)

A cAMP analog that activates PKA, potentially leading to increased phosphorylation and activation of N4BP3.

(−)-Epinephrine

51-43-4sc-205674
sc-205674A
sc-205674B
sc-205674C
sc-205674D
1 g
5 g
10 g
100 g
1 kg
$41.00
$104.00
$201.00
$1774.00
$16500.00
(1)

Increases cAMP levels through G protein-coupled receptor signaling, leading to PKA activation and potential phosphorylation of N4BP3.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

A selective inhibitor of phosphodiesterase 4 (PDE4) which increases intracellular cAMP levels, leading to PKA activation and potential phosphorylation of N4BP3.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

A non-selective inhibitor of phosphodiesterase which increases cAMP levels, leading to PKA activation and potential phosphorylation of N4BP3.

Zaprinast (M&B 22948)

37762-06-4sc-201206
sc-201206A
25 mg
100 mg
$105.00
$250.00
8
(2)

Inhibits PDE5 leading to increased cAMP levels, which can result in PKA activation and subsequent phosphorylation of N4BP3.